Electromed

OverviewSuggest Edit

Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

The SmartVest System generates HFCWO, also known as High-Frequency Chest Compression, a technique for airway clearance therapy. The garment repeatedly compresses and releases the upper body at frequencies from 5 to 20 cycles per second creating a “mini cough”. Each compression (or oscillation) produces pulsations that thin and loosen secretions from the surfaces of the lung airways, thins mucus stuck in the lungs and propels them toward the mouth where they can be removed by normal coughing or suction.

TypePublic
Founded1992
HQNew Prague, MN, USMap
Websitesmartvest.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2019)119(-9%)
Revenue (FY, 2020)$32.5 M(+4%)
Share Price (Apr 2021)$10.1
Cybersecurity ratingAMore

Key People/Management at Electromed

Kathleen Skarvan

Kathleen Skarvan

President & Chief Executive Officer
Mike MacCourt

Mike MacCourt

Chief Financial Officer
Kristine Owata

Kristine Owata

Vice President of Reimbursement & Payer Relations
Show more

Electromed Office Locations

Electromed has an office in New Prague
New Prague, MN, US (HQ)
500 6th Ave NW
Show all (1)

Electromed Financials and Metrics

Electromed Revenue

Embed Graph
View revenue for all periods
Electromed's revenue was reported to be $32.47 m in FY, 2020
USD

Revenue (Q2, 2021)

9.5m

Gross profit (Q2, 2021)

7.5m

Gross profit margin (Q2, 2021), %

79.2%

Net income (Q2, 2021)

1.2m

EBIT (Q2, 2021)

1.6m

Market capitalization (7-Apr-2021)

87.0m

Closing stock price (7-Apr-2021)

10.1

Cash (31-Dec-2020)

11.7m

EV

75.3m
Electromed's current market capitalization is $87 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

19.5m15.1m15.5m19.4m23.0m25.9m28.7m31.3m32.5m

Revenue growth, %

25%18%

Cost of goods sold

5.4m4.7m4.9m5.8m5.1m5.3m5.8m7.5m7.3m

Gross profit

14.1m10.4m10.6m13.6m17.9m20.6m22.9m23.8m25.2m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Revenue

5.4m4.8m4.8m4.0m3.9m3.2m3.4m3.5m4.0m4.8m4.9m4.6m5.0m6.3m6.0m5.5m6.4m6.7m6.4m7.0m7.1m7.3m8.0m7.4m8.3m8.5m8.7m9.5m

Cost of goods sold

1.3m1.3m1.4m1.2m1.3m756.7k1.1m978.0k1.4m1.5m1.5m1.4m1.1m1.4m1.4m1.2m1.4m1.4m1.4m1.4m1.5m1.7m2.0m1.8m2.0m1.9m2.2m2.0m

Gross profit

4.1m3.5m3.4m2.8m2.5m2.4m2.4m2.5m2.5m3.3m3.4m3.2m3.9m4.9m4.6m4.3m4.9m5.3m4.9m5.6m5.6m5.5m6.1m5.6m6.3m6.7m6.6m7.5m

Gross profit Margin, %

75%73%71%70%65%76%69%72%64%69%70%69%77%78%77%78%77%80%77%80%79%76%76%75%76%78%75%79%
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

1.7m503.6k1.5m3.6m5.1m5.6m7.5m7.8m10.5m

Accounts Receivable

10.9m9.0m6.5m6.5m7.6m9.9m11.6m12.8m12.9m

Prepaid Expenses

359.6k428.8k397.9k397.8k393.3k832.2k353.2k353.3k

Inventories

2.4m1.4m2.2m2.1m2.5m2.6m2.4m2.6m3.1m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Cash

2.9m1.7m1.4m1.5m1.0m505.0k1.1m1.2m772.4k2.3m2.5m2.9m3.8m4.5m4.9m3.8m4.8m5.4m5.8m6.8m7.1m7.7m7.2m7.5m8.0m9.2m9.9m11.7m

Accounts Receivable

10.4m10.7m11.1m10.4m9.7m9.2m8.0m7.0m6.5m6.4m6.6m6.4m6.5m6.9m7.3m8.0m8.3m8.9m9.6m9.7m10.1m11.5m11.9m12.3m12.7m12.7m13.3m15.4m

Prepaid Expenses

419.2k467.0k515.0k463.4k358.9k465.0k460.9k298.6k448.3k485.7k372.2k481.5k501.0k341.5k442.6k497.4k425.9k492.0k565.9k379.7k483.8k415.5k329.3k400.8k476.1k313.4k361.0k381.8k

Inventories

2.2m2.4m2.4m2.3m1.9m2.1m1.4m2.3m2.6m2.2m2.2m2.4m2.2m2.4m2.3m2.6m2.6m2.6m2.5m2.4m2.2m2.8m2.7m2.7m2.7m2.7m2.6m2.6m
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

186.6k(1.3m)(1.3m)1.1m2.2m2.2m1.9m2.0m4.2m

Depreciation and Amortization

408.6k459.8k695.5k736.2k738.7k755.1k790.0k925.2k738.2k

Inventories

(536.5k)1.0m(855.9k)163.4k(347.6k)(28.3k)234.6k(106.2k)(449.3k)

Accounts Payable

(58.6k)(77.8k)(302.3k)384.0k873.8k(337.5k)556.0k(2.6k)(472.6k)
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Net Income

245.5k270.1k365.2k(71.1k)(482.3k)(913.3k)(335.4k)(574.7k)(1.6m)377.5k800.2k837.5k341.0k1.4m1.9m191.2k635.0k1.3m121.1k470.4k783.2k154.4k532.1k882.3k1.0m2.2m2.9m1.7m

Depreciation and Amortization

90.6k193.8k300.2k115.0k231.9k344.7k154.5k322.3k504.7k186.2k370.2k557.2k185.5k369.1k550.7k186.5k373.0k563.6k192.3k386.3k581.0k164.7k389.8k617.2k180.9k379.2k560.6k315.6k

Inventories

(307.8k)(541.7k)(556.0k)87.1k493.4k251.0k(52.6k)(887.1k)(1.2m)(7.7k)1.0k(166.4k)(67.1k)(290.6k)(220.4k)(100.6k)(53.9k)(65.6k)115.6k183.6k373.4k(349.4k)(242.5k)(205.5k)(118.5k)(19.4k)(13.9k)490.4k

Accounts Payable

(40.8k)(343.1k)(296.2k)(347.2k)(75.0k)5.1k161.1k407.3k184.3k314.9k74.0k319.7k(171.3k)151.1k583.6k(1.2m)(807.2k)(323.5k)(36.9k)(149.6k)(55.0k)(103.3k)(233.8k)(63.8k)(250.0k)(427.4k)136.4k494.4k
show all
USDQ1, 2012

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.4 x
Show all financial metrics

Electromed Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

Learn more about our premium products
SecurityScorecard logo

Electromed Online and Social Media Presence

Electromed's Trends

Embed Graph

Electromed News and Updates

May 09, 2018

Electromed's (ELMD) CEO Kathleen Skarvan on Q3 2018 Results - Earnings Call Transcript

Electromed Blogs

March 09, 2021

Managing Breathlessness

We all experience breathlessness for different reasons: playing tag with our grandchildren, working out at the local gym, or even going for a walk on a humid, 90-degree day can cause anyone to feel out of breath. Shortness of breath is not only an uncomfortable experience, but it’s also an unsettlin…
March 05, 2021

How Is COPD Diagnosed?

If you’re experiencing shortness of breath, fatigue, or chronic cough, it might be time to speak to your doctor about getting tested for COPD (chronic obstructive pulmonary disease). COPD is a serious lung condition that a person can develop from long-term exposure to tobacco smoke, chemicals, fumes…
February 23, 2021

Prescribing Effective Airway Clearance Just Got Easier

Hospital administrations are feeling the pressure to reduce readmissions of patients experiencing frequent exacerbations of their chronic lung condition, like bronchiectasis or COPD.  Similarly, clinicians all over the country are challenged with finding the most effective treatment option to help p…
February 18, 2021

Understanding Cystic Fibrosis: Causes, Symptoms, and Treatment

Cystic fibrosis (CF), unlike chronic obstructive pulmonary disease (COPD) or bronchiectasis, is a genetic condition that affects more than 30,000 people in the United States.[1] According to the Cystic Fibrosis Foundation, “People with CF have inherited two copies of the defective CF gene—one copy f…
February 02, 2021

Benefits of Exercise with COPD

Staying active, eating healthy, and building muscle is good for the body and mind, especially if you’re living with a respiratory condition like chronic obstructive pulmonary disease (COPD). However, you may find it more challenging than others to exercise on a regular basis if you’re experiencing a…
January 27, 2021

Can the Cold Exacerbate COPD and Cystic Fibrosis Symptoms?

As we brace ourselves for another winter season, many people living with COPD and cystic fibrosis are taking extra precautions this year to protect their lungs against the colder temperatures and drier air conditions, all of which are known to exacerbate symptoms.[1] In a previous article, we shared…
Show more

 Electromed Frequently Asked Questions

  • When was Electromed founded?

    Electromed was founded in 1992.

  • Who are Electromed key executives?

    Electromed's key executives are Kathleen Skarvan, Mike MacCourt and Kristine Owata.

  • How many employees does Electromed have?

    Electromed has 119 employees.

  • What is Electromed revenue?

    Latest Electromed annual revenue is $32.5 m.

  • What is Electromed revenue per employee?

    Latest Electromed revenue per employee is $272.9 k.

  • Who are Electromed competitors?

    Competitors of Electromed include Hill-Rom Holdings, TruHearing and Predictive Oncology.

  • Where is Electromed headquarters?

    Electromed headquarters is located at 500 6th Ave NW, New Prague.

  • Where are Electromed offices?

    Electromed has an office in New Prague.

  • How many offices does Electromed have?

    Electromed has 1 office.